ZURA

Zura Bio Limited

There isn't enough reported data to score ZURA yet.

ZURA Fundamentals

MetricStatus
Unavailable
Weak
Unavailable
Strong

ZURA's balance sheet is currently strong, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.

ZURA PE Valuation

ZURA has no meaningful PE right now: it lost money over the past year.

ZURA Forward outlook

MetricOutlook
--
Losses steady
--
--
Limited
Low

Analysts expect ZURA's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.

ZURA Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $1.24 on Nov 12.

There is not enough scenario data to assess ZURA's risk to reward.

ZURA Earnings Per Share

Q1 2025: $-0.77Q2 2025: $-0.77Q3 2025: $-0.72Q4 2025: $-1.06Q1 2026: $-1.09Q2 2026: $-1.13Q3 2026: $-1.12
Q1 2025: $-0.77Q2 2025: $-0.77Q3 2025: $-0.72Q4 2025: $-1.06Q1 2026: $-1.09Q2 2026: $-1.13Q3 2026: $-1.12
QuarterTTM EPSYoY
Q3 2026-$1.12-$0.40
Q2 2026-$1.13-$0.36
Q1 2026-$1.09-$0.32

ZURA lost $1.12 per share over the past year, a bigger loss than the year before.

ZURA Quarterly Revenue

Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --
Q4 2023: --Q1 2024: --Q2 2024: --Q3 2024: --Q4 2024: --Q1 2025: --Q2 2025: --Q3 2025: --Q4 2025: --Q1 2026: --Q2 2026: --Q3 2026: --

ZURA Free Cash Flow

Q4 2023: โˆ’$4MQ1 2024: โˆ’$5MQ2 2024: โˆ’$7MQ3 2024: โˆ’$6MQ4 2024: โˆ’$11MQ1 2025: โˆ’$11MQ2 2025: โˆ’$16MQ3 2025: โˆ’$15MQ4 2025: โˆ’$22MQ1 2026: โˆ’$19MQ2 2026: --Q3 2026: --
Q4 2023: โˆ’$4MQ1 2024: โˆ’$5MQ2 2024: โˆ’$7MQ3 2024: โˆ’$6MQ4 2024: โˆ’$11MQ1 2025: โˆ’$11MQ2 2025: โˆ’$16MQ3 2025: โˆ’$15MQ4 2025: โˆ’$22MQ1 2026: โˆ’$19MQ2 2026: --Q3 2026: --
QuarterFree cash flowYoY
Q1 2026-$18.9M-$7.8M
Q4 2025-$22.3M-$11.4M
Q3 2025-$15.5M-$9.8M
Q2 2025-$16M-$9.4M
Q1 2025-$11.1M-$6.1M
Q4 2024-$10.9M-$6.8M
Q3 2024-$5.7M-$3.1M
Q2 2024-$6.6M-$1.5M

ZURA has burned cash in almost every quarter: โˆ’$73M over the past year, against โˆ’$34M the year before.

ZURA Total Shares

Q2 2024: 75MQ3 2024: 87MQ4 2024: 75MQ1 2025: 93MQ2 2025: 94MQ3 2025: 95MQ4 2025: 94MQ1 2026: 112MQ2 2026: 127MQ3 2026: 128M
Q2 2024: 75MQ3 2024: 87MQ4 2024: 75MQ1 2025: 93MQ2 2025: 94MQ3 2025: 95MQ4 2025: 94MQ1 2026: 112MQ2 2026: 127MQ3 2026: 128M
PeriodChange %Net change
Quarterly+0.7%+909K shares
1 year+35%+33.1M shares

ZURA has 128M diluted shares, up 35% from a year ago.

ZURA Net Leverage

QuarterNet LeverageStatus
Q1 2022-0.7xNet Cash
Q4 2021-0.1xNet Cash

ZURA has more cash than debt.

ZURA Weekly Momentum

MetricValueStatus
RSI27.9Oversold
Stochastic15.7Oversold

ZURA's weekly RSI is 28 (oversold) and its Stochastic is 16 (oversold).

ZURA PE vs Healthcare Sector

ZURA has no meaningful PE right now: it lost money over the past year.

ZURA Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.5965% below
20 week MA$4.7174% below
50 week MA$5.0175% below
100 week MA$3.4964% below

ZURA is in a downtrend: it's below all four of its weekly moving averages, and 64% below its 100-week average.

ZURA Yearly ROI

YearStart priceEnd priceROI
2023$29.4$4.67-84%
2024$4.67$2.50-46%
2025$2.50$4.65+86%
2026 YTD$4.65$1.24-73%

ZURA has finished lower in two of the last three years. It's down 73% so far in 2026.

Give your agent the market.

Get API key